Cite
HARVARD Citation
Lee, J. et al. (2022). Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer. Therapeutic advances in medical oncology. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lee, J. et al. (2022). Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer. Therapeutic advances in medical oncology. p. . [Online].